Sponsor-side execution intelligence
Heralink helps clinical trial sponsors and clinical investors evaluate vendors, pressure-test execution plans, and recover stalled study operations across China and global markets.
Resource, quality and execution risk are reviewed in one operating view instead of being scattered across vendor introductions.
We translate protocol demands, site reality, vendor capability, quality risk, and cross-border constraints into a decision-ready operating plan.
The work is not a generic lead list. Each engagement is framed around the sponsor's risk profile, timeline, budget sensitivity, and evidence requirements.